chevron_leftBack
As of 24 April 2025, Yuhan Corp. has a market cap of $6.06B USD, ranking #2467 globally and #50 in South Korea. It ranks #209 in the Healthcare sector, and #34 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$6.06BUSD
8.7T KRW
Enterprise Value
$6.11BUSD
8.72T KRW
Revenue (TTM)
$1.44BUSD
2.07T KRW
EBITDA (TTM)
$82.61MUSD
117.91B KRW
Net Income (TTM)
$49.24MUSD
70.69B KRW
EBITDA Margin
5.7%
Profit Margin
3.4%
PE Ratio
129.4
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Wook-Je Cho
open_in_new
Employees
1,999
Founded
1926
Website
yuhan.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.1% | 1.8% | -4.7% | -12% | -28% | 67% |
Upcoming Earnings
Earnings Date
Thu, May 15
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
000100
(주)유한양행
ISIN: KR7000100008
Shares Out.:
Shares Outstanding:
73.83M1
Shares Float:
55.889M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
115.5K KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Yuhan Corp.
Yuhan Corporation manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally. It also manufactures and sells animal feed and health functional food. The company was founded in 1926 and is headquartered in Seoul, South Korea.
